Evidence in adenoid cystic carcinoma with low TMB and lower immune infiltration demonstrated that recurrent MYB-NFIB fusions also exhibit immunogenic peptides in approximately 60% of patients (14). The gene discussed is MYB; the disease is adenoid cystic carcinoma.